FemTech Insight Digest

Maternal Health Policy Shifts

• 🔥 Removal of 'Black' from Momnibus Bills: The word 'Black' has been almost completely removed from the latest...

The latest Momnibus Act has dropped most references to 'Black' from its title and text, evolving from over a dozen mentions in 2020 to just one in...

Dr. Mary Claire Haver translates complex research into practical strategies for perimenopause and post-menopause, emphasizing quality of life and...

Dr. Christine Vaccaro highlights how women's sexual health remains poorly understood, urging clearer conversations on hormones, libido, and pelvic...

MENA Funding Activity

• 🔥 RSA XB Seed Round: UAE-based RSA XB raised $1.5 million in a seed round led by 21 Ventures and spun off from RSA Global...

The Founder Institute implements a unique gender-blind evaluation model for its pre-seed program to ensure applicants are judged solely on merit and...

Women's health R&D receives just one-fifth of total funding, with most concentrated in ovarian cancer and menopause, leaving conditions like ischemic...

UAE-based RSA XB's $1.5 million seed round, spun off from RSA Global and led by 21 Ventures, offers a clear emerging-market model of cross-border health logistics innovation with direct implications for reimbursement and health-system implementation.

Research calls targeting menopausal disorders are generating new knowledge across the life course, while plan sponsors explore dedicated midlife...

US Policy Shift in Menopause Care

• 🔥 Advancing Menopause Care and Mid-Life Women's Health Act: The Act introduces new US public funding and...

Emily's $250M AUM VC team targets women's health alongside Medicare and Medicaid to navigate health plan innovation failures and drive scalable adoption.

Hormone shifts in perimenopause are worsening IBS and gut symptoms by altering the microbiome, digestion, and inflammation.

• Experts link...

The Advancing Menopause Care and Mid-Life Women's Health Act increases public health activities addressing chronic conditions linked to menopause...

Clinical Research Highlights

• 🔥 PCOS Rebranded as PMOS: Article titled 'PCOS is now PMOS. Here's why' covers the rebranding and dives into...

PCOS is now PMOS, tying into women's healthcare market trends and facility data insights for enhanced FemTech positioning.

Trillions to women: Over next 30 years, massive capital shift to women’s hands, reshaping economy and sustainability.

• Gender differences: Women...

JAHA study validates perimenopause as CVD inflection point:

• Perimenopausal women face nearly 2x odds of poor Life’s Essential 8 score (aOR 1.92) vs....

Health Tech Funding Signals

• 🔥 Forum Ventures Pre-Seed Fund: Forum Ventures' Pre-Seed Fund invests $250k–$1M in early-stage B2B health tech...

UK NHS renewed strategy for women's health MedTech innovations is backed by record £26 billion investment, including a £1.5 million FemTech Challenge Fund—key non-dilutive opportunity for FemTech founders and implementers.

Core benchmarks for $250k–$1M investments:

• Early-stage B2B companies with MVP in market
• Meaningful traction required
  Health tech example: Remo Health in portfolio. Founders, prioritize these for VC readiness.